The relative insufficiency of insulin secretion and/or insulin action causes diabetes.
However, obesity and type 2 diabetes mellitus can be associated with an absolute increase …

Background: Diabetes mellitus is associated with an increased risk of breast cancer, but
studies of the effects of diabetes on the prognosis of women with breast cancer have yielded …

Introduction Metformin use has recently been observed to decrease both the rate and
mortality of breast cancer. Our study was aim to determine whether metformin use is …

Metformin is one of the most used diabetic drugs for the management of type II diabetes
mellitus (DM) in the world. Increased numbers of epidemiological and clinical studies have …

Metabolic disorders, especially type 2 diabetes and its associated complications, represent
a growing public health problem. Epidemiological findings indicate a close relationship …

Background: Although research suggests that type II diabetes mellitus (DM-2) is associated
with overall and breast cancer–specific decreased survival, most prior studies of breast …

The worldwide epidemic of obesity is associated with increasing rates of the metabolic
syndrome and type 2 diabetes. Epidemiological studies have reported that these conditions …

Introduction While type 2 diabetes (T2D) has been associated with increased all-cause
mortality among women diagnosed with breast cancer (BC), the association between T2D …

Research suggests that metformin may be associated with improved survival in cancer
patients with type II diabetes. This study assessed whether metformin use after non‐small …

Observational data suggest that metformin use decreases breast cancer (BC) incidence in
women with diabetes; the impact of metformin on BC outcomes in this population is less …